Moderna Inc MRNA:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 7:59 PM EDT
119.48quote price arrow down-0.21 (-0.18%)
Volume
154,998
Close
119.69quote price arrow down-3.95 (-3.19%)
Volume
3,650,849
52 week range
115.61 - 434.00
Loading...
  • Open123.34
  • Day High125.88
  • Day Low119.56
  • Prev Close123.64
  • 52 Week High434.00
  • 52 Week High Date09/27/21
  • 52 Week Low115.61
  • 52 Week Low Date06/13/22

Key Stats

  • Market Cap46.823B
  • Shares Out391.20M
  • 10 Day Average Volume5.95M
  • Dividend-
  • Dividend Yield-
  • Beta1.70
  • YTD % Change-52.87

KEY STATS

  • Open123.34
  • Day High125.88
  • Day Low119.56
  • Prev Close123.64
  • 52 Week High434.00
  • 52 Week High Date09/27/21
  • 52 Week Low115.61
  • 52 Week Low Date06/13/22
  • Market Cap46.823B
  • Shares Out391.20M
  • 10 Day Average Volume5.95M
  • Dividend-
  • Dividend Yield-
  • Beta1.70
  • YTD % Change-52.87

RATIOS/PROFITABILITY

  • EPS (TTM)32.80
  • P/E (TTM)3.65
  • Fwd P/E (NTM)7.65
  • EBITDA (TTM)15.945B
  • ROE (TTM)113.86%
  • Revenue (TTM)22.995B
  • Gross Margin (TTM)82.29%
  • Net Margin (TTM)61.12%
  • Debt To Equity (MRQ)4.24%

EVENTS

  • Earnings Date11/02/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Related Video

Pro Picks: Watch all of Tuesday's big stock calls on CNBC
VIDEO6:5106:51
Pro Picks: Watch all of Tuesday's big stock calls on CNBC

Profile

MORE
Moderna, Inc. is a biotechnology company that is focused on creating a transformative medicines based on messenger ribonucleic acid (mRNA), to improve the lives of patients. The Company’s mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane, or secreted proteins that have a therapeutic or preventive benefit with the potential to address a range of spectrum of diseases. It is developing vaccines and therapeutics for infectious diseases...
Noubar Afeyan Ph.D.
Non-Executive Independent Chairman of the Board, Co-Founder
Stephane Bancel
Chief Executive Officer, Director
Stephen Hoge M.D.
President
James Mock
Chief Financial Officer
Juan Andres
Chief Technical Operations and Quality Officer
Address
200 Technology Sq
Cambridge, MA
02139-3578
United States

Top Peers

SYMBOLLASTCHG%CHG
BNTX
BioNTech SE
127.65-0.70-0.55%
REGN
Regeneron Pharmaceuticals Inc
686.10-11.23-1.61%
BIIB
Biogen Inc
195.75-2.03-1.03%
ILMN
Illumina Inc
184.12-6.26-3.29%
ALNY
Alnylam Pharmaceuticals Inc
197.39-3.39-1.69%